glp 1 drug prices GLP-1 Side Effects Have a Side Effect on Pharmacy Costs| AMCP Annual 2025 GLP-1 Antagonists Increase Plan Drug
Description
Out of all patients with an overweight or obesity diagnosis who were prescribed a GLP-1 drug, the percentage of patients who had behavioral health services related to their condition declined from 2019 to 2024
In 2014, liraglutide was approved for chronic weight management in patients aged 12 years meeting specific BMI thresholds [19, 22]
doi: 10.1046/j.1365-2036.2003.01553.x
doi: 10.1016/j.lfs.2020.118645 [DOI] [PubMed] [Google Scholar] 139
10.1186/s12933-018-0800-2 86
